Document and Entity Information
Document and Entity Information | May 10, 2023 |
Cover [Abstract] | |
Entity Registrant Name | CTI BIOPHARMA CORP |
Security Exchange Name | NASDAQ |
Amendment Flag | false |
Entity Central Index Key | 0000891293 |
Current Fiscal Year End Date | --12-31 |
Document Type | 8-K |
Document Period End Date | May 10, 2023 |
Entity Incorporation State Country Code | DE |
Entity File Number | 000-28386 |
Entity Tax Identification Number | 91-1533912 |
Entity Address, Address Line One | 3101 Western Avenue |
Entity Address, Address Line Two | Suite 800 |
Entity Address, City or Town | Seattle |
Entity Address, State or Province | WA |
Entity Address, Postal Zip Code | 98121 |
City Area Code | (206) |
Local Phone Number | 282-7100 |
Written Communications | false |
Soliciting Material | false |
Pre Commencement Tender Offer | false |
Pre Commencement Issuer Tender Offer | false |
Security 12b Title | Common Stock, par value $0.001 |
Trading Symbol | CTIC |
Entity Emerging Growth Company | false |